BTI
British American Tobacco p.l.c.
Stock
$52.64−0.55 (−1.03%)Close Oct 2, 2026
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | £25.6B | £25.9B | £27.3B | £27.7B | £25.7B | £25.8B | £25.9B | £24.5B | £19.6B | £14.1B | £13.1B |
| R&D | £358M | £380M | £408M | £323M | £304M | £307M | £376M | £258M | £191M | £144M | £60M |
| Operating income | £10.0B | £2.7B | −£15.8B | £10.5B | £10.2B | £10.0B | £9.0B | £9.3B | £6.4B | £4.7B | £4.6B |
| Non-operating income | −£138M | £802M | −£1.3B | −£1.2B | −£1.1B | −£1.3B | −£1.1B | −£962M | £23.1B | £1.6B | £1.3B |
| Pretax income | £9.9B | £3.5B | −£17.1B | £9.3B | £9.2B | £8.7B | £7.9B | £8.4B | £29.5B | £6.2B | £5.9B |
| Taxes | £2.1B | £470M | −£2.7B | £2.7B | £2.4B | £2.3B | £2.2B | £2.3B | −£8.0B | £1.6B | £1.6B |
| Net income | £7.8B | £3.1B | −£14.4B | £6.7B | £6.8B | £6.4B | £5.7B | £6.0B | £37.5B | £4.6B | £4.3B |
| Diluted EPS | £3.49 | £1.36 | −£6.47 | £2.92 | £2.96 | £2.79 | £2.49 | £2.63 | £18.28 | £2.49 | £230.30 |
| Diluted shares | 2.20B | 2.23B | 2.23B | 2.27B | 2.30B | 2.30B | 2.29B | 2.29B | — | — | — |
| Revenue growth | −1.0% | −5.2% | −1.3% | +7.7% | −0.4% | −0.4% | +5.7% | +25.2% | +38.5% | +7.8% | — |
| Operating margin | 39.0% | 10.6% | −57.7% | 38.1% | 39.8% | 38.6% | 34.8% | 38.0% | 32.8% | 32.9% | 34.8% |
| Net margin | 30.3% | 11.9% | −52.7% | 24.1% | 26.5% | 24.8% | 22.0% | 24.6% | 191.6% | 32.9% | 32.7% |